• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2002 Fiscal Year Final Research Report Summary

Development of a gene set and monoclonal antibodies for the diagnosis of hepatocellular carcinoma.

Research Project

Project/Area Number 12557051
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section展開研究
Research Field Gastroenterology
Research InstitutionThe University of Tokyo

Principal Investigator

ABURATANI Hiroyuki  The University of Tokyo, Center for Collaborative Research, Professor, 国際・産学共同研究センター, 教授 (10202657)

Co-Investigator(Kenkyū-buntansha) YAMASHITA Naohiko  Institute of Immunology Co., Ltd, Antibody Development Division, Researcher, 研究員
KODAMA Tatsuhiko  The University of Tokyo, Center for Collaborative Research, Professor, 先端科学技術研究センター, 教授 (90170266)
Project Period (FY) 2000 – 2002
Keywordsmicroarray / tumor marker / GPC3 / hepatocellular carcinoma
Research Abstract

We aimed at developing a novel algorithm for diagnosis of hepatocellular carcinoma (HCC) by analyzing a correlation between gene expression profiles and clinical and/or pathological parameters. Particularly we analyzed the function of HCC-specific genes and its role in hepatocarcinogenesis. We performed gene expression profiling analysis to identify a novel marker for diagnosis and therapeutics.
1)Novel algorithms, using cluster analysis, PCA and SVM, were developed to analyze gene expression data for discrimination between cancer and normal tissues and gene selection for prognosis estimation.
2)With gene expression profiling of nodule-in-nodule type of HCC, we identified 16 genes differentially expressed between well differentiated and moderately differentiated tumors.
3)We demonstrated GPC3 protein level is elevated in HCCs as well as its RNA level and that GPC3 inhibits BMP-7 signaling through the Smad pathway by reporterr gene assay. It is a heparan sulfate proteoglycan anchored to the plasma membrane we demonstrated that its NH(2)-terminal portion [soluble GPC3 (sGPC3)] is cleaved between Arg(358) and Ser(359) of GPC3 and that sGPC3 can be specifically detected in the sera of patients with HCC.
4) In immunohistochemistry GPC3 is positive in 84% of HCC cases.

  • Research Products

    (10 results)

All Other

All Publications (10 results)

  • [Publications] Hippo Y, Watanabe K, Watanabe A, Midorikawa Y, Yamamoto S, Ihara S, Tokita S, Iwanari H, Ito Y, Nakano K, Nezu J, Tsunoda H, Yoshino T, Ohizumi I, Tsuchiya M, Ohnishi S, Makuuchi M, Hamakubo T, Kodama T, Aburatani H.: "Identification of Soluble Amino Terminal Fragment of Glypican-3 as a Serological Marker for Early Stage Hepatocellular Carcinoma."Cancer Research. 64. 2418-2423 (2004)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ge X, Tsustumi S, Aburatani H, Iwata S.: "Reducing false positives in molecular pattern recognition."Genome Informatics. 14. 34-43 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kano M, Nishimura K, Ishikawa S, Tsutsumi S, Hirota K, Hirose M, Aburatani H.: "Expression Imbalance Map : A New Visualization Method for Detection of mRNA Expression Imbalance Regions."Physiol Genomics. 13. 31-46 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Midorikawa Y, Ishikawa S, Iwanari H, Imamura T, Sakamoto H, Miyazono K, Kodama T, Makuuchi M, Aburatani H.: "Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling."Int J Cancer.. 103(4). 455-465 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Midorikawa Y, Tsutsumi S, Taniguchi H, Ishii M, Kobune Y, Kodama T, Makuuchi M, Aburatani H.: "Identification of genes associated with dedifferentiation of hepatocellular carcinoma with expression profiling analysis."Jpn J Cancer Res. 93(6). 636-643 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Hippo Y, Watanabe K, Watanabe A, Midorikawa Y, Yamamoto S, Ihara S, Tokita S, Iwanari H, Ito Y, Nakano K, Nezu J, Tsunoda H, Yoshino T, Ohizumi I, Tsuchiya M, Ohnishi S, Makuuchi M, Hamakubo T, Kodama T, Aburatani H.: "Identification of Soluble Amino Terminal Fragment of Glypican-3 as a Serological Marker for Early Stage Hepatocellular Carcinoma."Cancer Research. 64. 2418-2423 (2004)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ge X, Tsustumi S, Aburatani H, Iwata S.: "Reducing false positives in molecular pattern recognition."Genome Informatics. 14. 34-43 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kano M, Nishimura K, Ishikawa S, Tsutsumi S, Hirota K, Hirose M, Aburatani H.: "Expression Imbalance Map : A New Visualization Method for Detection of mRNA Expression Imbalance Regions."Physiol Genomics. 13. 31-46 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Midorikawa Y, Ishikawa S, Iwanari H, Imamura T, Sakamoto H, Miyazono K, Kodama T, Makuuchi M, Aburatani H.: "Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling."Int J Cancer. 103(4). 455-465 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Midorikawa Y, Tsutsumi S, Taniguchi H, Ishii M, Kobune Y, Kodama T, Makuuchi M, Aburatani H.: "Identification of genes associated with dedifferentiation of hepatocellular carcinoma with expression profiling analysis."Jpn J Cancer Res.. 93(6). 636-643 (2002)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2005-04-19  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi